Stereotaxis Statistics
Total Valuation
Stereotaxis has a market cap or net worth of $226.78 million. The enterprise value is $221.86 million.
Important Dates
The last earnings date was Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Stereotaxis has 93.32 million shares outstanding. The number of shares has increased by 5.35% in one year.
| Current Share Class | 93.32M |
| Shares Outstanding | 93.32M |
| Shares Change (YoY) | +5.35% |
| Shares Change (QoQ) | +4.62% |
| Owned by Insiders (%) | 11.26% |
| Owned by Institutions (%) | 30.78% |
| Float | 66.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.16 |
| Forward PS | 5.63 |
| PB Ratio | 35.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.31 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -170.24% and return on invested capital (ROIC) is -64.59%.
| Return on Equity (ROE) | -170.24% |
| Return on Assets (ROA) | -26.42% |
| Return on Invested Capital (ROIC) | -64.59% |
| Return on Capital Employed (ROCE) | -80.89% |
| Revenue Per Employee | $216,367 |
| Profits Per Employee | -$179,165 |
| Employee Count | 139 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.91% in the last 52 weeks. The beta is 1.47, so Stereotaxis's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | +9.91% |
| 50-Day Moving Average | 2.80 |
| 200-Day Moving Average | 2.37 |
| Relative Strength Index (RSI) | 46.71 |
| Average Volume (20 Days) | 699,854 |
Short Selling Information
The latest short interest is 2.93 million, so 3.14% of the outstanding shares have been sold short.
| Short Interest | 2.93M |
| Short Previous Month | 3.06M |
| Short % of Shares Out | 3.14% |
| Short % of Float | 4.43% |
| Short Ratio (days to cover) | 4.63 |
Income Statement
In the last 12 months, Stereotaxis had revenue of $30.08 million and -$24.90 million in losses. Loss per share was -$0.28.
| Revenue | 30.08M |
| Gross Profit | 15.96M |
| Operating Income | -20.40M |
| Pretax Income | -23.63M |
| Net Income | -24.90M |
| EBITDA | -18.88M |
| EBIT | -20.40M |
| Loss Per Share | -$0.28 |
Full Income StatementBalance Sheet
The company has $10.51 million in cash and $5.58 million in debt, giving a net cash position of $4.92 million or $0.05 per share.
| Cash & Cash Equivalents | 10.51M |
| Total Debt | 5.58M |
| Net Cash | 4.92M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 11.53M |
| Book Value Per Share | 0.07 |
| Working Capital | 6.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.45 million and capital expenditures -$25,000, giving a free cash flow of -$8.48 million.
| Operating Cash Flow | -8.45M |
| Capital Expenditures | -25,000 |
| Free Cash Flow | -8.48M |
| FCF Per Share | -$0.09 |
Full Cash Flow StatementMargins
Gross margin is 53.07%, with operating and profit margins of -67.83% and -78.56%.
| Gross Margin | 53.07% |
| Operating Margin | -67.83% |
| Pretax Margin | -78.56% |
| Profit Margin | -78.56% |
| EBITDA Margin | -62.76% |
| EBIT Margin | -67.83% |
| FCF Margin | n/a |
Dividends & Yields
Stereotaxis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.35% |
| Shareholder Yield | -5.35% |
| Earnings Yield | -10.98% |
| FCF Yield | -3.74% |
Analyst Forecast
The average price target for Stereotaxis is $4.00, which is 64.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 64.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2012. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Stereotaxis has an Altman Z-Score of -15.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.01 |
| Piotroski F-Score | 2 |
